Rafferty Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Buy |
16,984
+3,066
| +22% | +$24.8K | ﹤0.01% | 1063 |
|
|
2025
Q1 | $117K | Sell |
13,918
-1,745
| -11% | -$14.6K | ﹤0.01% | 1043 |
|
|
2024
Q4 | $124K | Sell |
15,663
-3,181
| -17% | -$25.2K | ﹤0.01% | 1119 |
|
|
2024
Q3 | $157K | Buy |
18,844
+1,597
| +9% | +$13.3K | ﹤0.01% | 1118 |
|
|
2024
Q2 | $110K | Buy |
17,247
+2,106
| +14% | +$13.4K | ﹤0.01% | 1159 |
|
|
2024
Q1 | $91.8K | Buy |
15,141
+3,348
| +28% | +$20.3K | ﹤0.01% | 1073 |
|
|
2023
Q4 | $71.6K | Buy |
+11,793
| New | +$71.6K | ﹤0.01% | 1068 |
|
|
2022
Q3 | – | Sell |
-33,067
| Closed | -$105K | – | 1148 |
|
|
2022
Q2 | $105K | Buy |
33,067
+8,344
| +34% | +$26.5K | ﹤0.01% | 1069 |
|
|
2022
Q1 | $103K | Sell |
24,723
-12,651
| -34% | -$52.7K | ﹤0.01% | 1170 |
|
|
2021
Q4 | $179K | Sell |
37,374
-575
| -2% | -$2.75K | ﹤0.01% | 1235 |
|
|
2021
Q3 | $203K | Buy |
37,949
+23,267
| +158% | +$124K | ﹤0.01% | 1192 |
|
|
2021
Q2 | $75K | Buy |
+14,682
| New | +$75K | ﹤0.01% | 1251 |
|
|
2021
Q1 | – | Sell |
-17,323
| Closed | -$79K | – | 1160 |
|
|
2020
Q4 | $79K | Buy |
17,323
+2,956
| +21% | +$13.5K | ﹤0.01% | 1006 |
|
|
2020
Q3 | $56K | Buy |
14,367
+2,517
| +21% | +$9.81K | ﹤0.01% | 948 |
|
|
2020
Q2 | $56K | Buy |
+11,850
| New | +$56K | ﹤0.01% | 968 |
|